# Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

> **NCT00997152** · PHASE2 · TERMINATED · sponsor: **Akros Pharma Inc.** · enrollment: 152 (actual)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** JTT-654
- **DRUG:** JTT-654 Placebo

## Key facts

- **NCT ID:** NCT00997152
- **Lead sponsor:** Akros Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2013-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997152, "Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00997152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*